SCHEMBL29965390

SCHEMBL29965390

COc1ccc(Oc2c(Cl)cc(Br)cc2Cl)cc1S(=O)(=O)Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV4 Q9HBA0 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ THRB P10828 2/20 0.41
▸ RORC P51449 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ TP53 P04637 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ GAA P10253 1/20 0.40
▸ KMT2A Q03164 2/20 0.39
▸ TSHR P16473 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ ACLY P53396 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ POLB P06746 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663112 1.00 TRPV4 (0.43) TRPV4ALDH1A1NPSR1THRBRORC
SCHEMBL23663236 0.89 SMN1; SMN2 (0.48) ALDH1A1NPSR1THRBRORCL3MBTL1
SCHEMBL31192656 0.88 THRB (0.43) ALDH1A1NPSR1THRBRORCL3MBTL1
SCHEMBL23663257 0.88 PKM (0.45) ALDH1A1NPSR1THRBRORCL3MBTL1
SCHEMBL29965585 0.88 PKM (0.45) ALDH1A1NPSR1THRBRORCL3MBTL1
SCHEMBL4961573 0.82 PDE7A (0.42) TRPV4ALDH1A1NPSR1THRBRORC
SCHEMBL7208834 0.82 PDE7A (0.42) TRPV4ALDH1A1NPSR1THRBRORC
SCHEMBL23663150 0.82 L3MBTL1 (0.57) ALDH1A1NPSR1L3MBTL1TP53SMN1; SMN2
SCHEMBL23663324 0.81 GAA (0.39) ALDH1A1NPSR1THRBRORCL3MBTL1
SCHEMBL23671415 0.81 ALDH1A1 (0.39) ALDH1A1NPSR1THRBRORCL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF ECCOGENE INC (US) 2025-10-16 — — US disclosed
US-12291518-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE INC. (US) 2025-05-06 — — US disclosed
CN-115244037-B Substituted triazinones as thyroid hormone receptor agonists 诚益生物(美国)公司 2024-10-25 — — CN disclosed
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 — — US disclosed
EP-4090652-A1 SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS Eccogene (Shanghai) Co., Ltd. (CN) 2022-11-23 — — EP disclosed
CN-115244037-A Substituted triazinones as thyroid hormone receptor agonists 上海诚益生物科技有限公司 2022-10-25 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB TRPV4 405/4885ALDH1A1 1862/4885NPSR1 111/4885
US-12291518-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB TRPV4 405/4885ALDH1A1 1862/4885NPSR1 111/4885
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF TSHR, THRA, THRB TRPV4 405/4885ALDH1A1 1862/4885NPSR1 111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback